Distribution of Lek's Products in U.S. Stopped
Ljubljana, 10 March - COMPANIES/LEK
The Ljubljana-based pharmaceutical company Lek must submit additional data and certificates about some of its products to the U.S. Food and Drug Administration (FDA). Distribution of Lek's products on the American market has therefore been stopped, the company informed its shareholders on Wednesday.
The rest of this news item is available to subscribers.
The news item consists of 400 characters (without spaces) or 78 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.